InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Wellington Biomedical Innovation Master Investors (Cayman) I L.P.. Director active across 6 companies, notably Verve Therapeutics, Inc.. Cumulatively, 6 disclosures have been logged. Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
180,635 股Common StockSEC:0001104659-24-101030:0
145,089 股Common StockSEC:0001415889-24-019908:0
189,933 股Common StockSEC:0001415889-24-009885:0
888,130 股Common StockSEC:0000950170-22-025513:0
897,671 股Class A Common StockSEC:0000899243-21-031393:0
1,343,081 股Common StockSEC:0000899243-21-025303:0
6 条申报中的 6 条
About Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is a declarant with 8 filings in total. Among the most recent filings held in the sample, they cover the period from 2021-06-22 to 2024-09-18, with 0 EUR of buys and 0 EUR of sells, and relate to Nuvalent, Inc., Verve Therapeutics, Inc., Zenas BioPharma, Inc., Artiva Biotherapeutics, Inc., Boundless Bio, Inc., and Acrivon Therapeutics, Inc.
